NCT04432727View on ClinicalTrials.gov

Study Evaluating Flexitouch Plus With Connectivity on Compliance in 30 Patients With Breast Cancer-Related Lymphedema.

NACompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

August 13, 2020

Primary Completion Date

November 19, 2021

Study Completion Date

November 19, 2021

Conditions
Breast Cancer Lymphedema
Interventions
DEVICE

Flexitouch Plus with Cellular Connectivity (FT-CC)

Daily use of FT-CC

Trial Locations (3)

12180

Samaritan Hospital Hildegard Medicus Cancer Center, Troy

12208

St. Peter's Hospital, Albany

40202

University of Louisville, Louisville

Sponsors

Lead Sponsor

Tactile Medical
All Listed Sponsors
lead

Tactile Medical

INDUSTRY

NCT04432727 - Study Evaluating Flexitouch Plus With Connectivity on Compliance in 30 Patients With Breast Cancer-Related Lymphedema. | Biotech Hunter | Biotech Hunter